NTLA Today - Jul 12: Stung by Phase 3 Data

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

NTLA Today - Jul 12: Stung by Phase 3 Data

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your friendly neighborhood investor here to break down what went down with Intellia, or NTLA. Today was a rough day for the stock, and it got smoked, dropping about 8%. Ouch, right?

So, here’s the scoop. Intellia started the day kinda strong but then took a nosedive after some news about their Phase 3 trial results for Lonvo-z. Even though the data was positive, it didn’t seem to sit well with investors. They hit that sell button pretty quick. I mean, when the market is feeling jittery, any little thing can make folks skittish.

Now, why did this happen? Well, the buzz around the stock was that even with the promising results, there were some big questions lingering about the future. They’ve got plans to launch in 2027, but that feels like forever away, right? Plus, there was chatter about Cathie Wood and her trades, which usually stirs the pot. But today, it was all about those Phase 3 results and what it means for the launch timeline. Investors are probably worried about the timeline and what it means for Intellia’s bottom line.

On a side note, Intellia has actually surged about 38% over the last month, so this drop is kinda surprising. It's like a reality check after a wild ride.

One thing worth keeping an eye on is how Intellia’s management responds to this dip. They might have some plans up their sleeve to reassure investors, but we'll see how that plays out.

So, to wrap it up, yeah, today was a tough day for NTLA. It’s always a rollercoaster in the stock market, and this one definitely had its downs today. Just remember, I’m here for the info and fun chat, not to dish out financial advice. Catch you later!

まだレビューはありません